Loading…
HealthStream, Inc. is projected to rise to $33.27 by 2027, a +19% move from its current price of $28.08. HSTM is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $27.66 | $28.08 | $28.51 | +0.02% |
| Jul 15 | $27.49 | $28.09 | $28.70 | +0.03% |
| Jul 16 | $27.37 | $28.09 | $28.84 | +0.05% |
| Jul 17 | $27.26 | $28.10 | $28.96 | +0.07% |
| Jul 18 | $27.17 | $28.10 | $29.07 | +0.08% |
| Jul 19 | $27.08 | $28.11 | $29.17 | +0.10% |
| Jul 20 | $27.01 | $28.11 | $29.26 | +0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $27.01 | $28.11 | $29.26 | +0.12% |
| Week 2 | $26.59 | $28.15 | $29.79 | +0.23% |
| Week 3 | $26.29 | $28.18 | $30.21 | +0.35% |
| Week 4 | $26.04 | $28.21 | $30.57 | +0.47% |
| Week 5 | $25.82 | $28.25 | $30.90 | +0.59% |
| Week 6 | $25.63 | $28.28 | $31.20 | +0.71% |
| Week 7 | $25.46 | $28.31 | $31.48 | +0.82% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company offers hStream, a technology platform; CredentialStream, provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure and other credentials, privileging, appointments by credentialing committees, enrollment, network, management, onboarding, and performance evaluations of providers; ShiftWizard; and Competency Suite, AI/ML-driven clinical competency development system.
It also provides applications for performance appraisal, competency management, disclosure management, clinical competency, assessment, development, simulation-based education, clinical rotation and onboarding management, quality management, and industry training. The company's solutions help healthcare organizations in meeting their ongoing learning, clinical development, credentialing, and scheduling needs. It serves the healthcare industry, including private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies, and nursing schools and students.
The company was incorporated in 1990 and is headquartered in Nashville, Tennessee.
HealthStream, Inc. (HSTM) is a healthcare software company providing SaaS solutions for U.S. healthcare organizations. The current price is $28.28 and the company carries a market cap of $826.21M, ranking 2711 by market capitalization.
The price outlook from the provided forecast shows a path of rising averages over time, with 2026 averaging $28.28 and a longer‑term trajectory toward substantially higher levels, including a 2030 average of $56.12 and a 2050 average of $331.17. These figures reflect a bullish long‑term tilt, with progressively higher averages across the forecast years.
A major floor 29.2% below — a decisive break under it would weaken the trend.
The nearest floor, 12.6% below — buyers have tended to step in here.
The nearest ceiling, 3.5% above — a clean break opens room to run.
A major ceiling 13.1% above — clearing it would confirm fresh momentum.
Key HSTM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HSTM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $28.36 | Sell | $28.12 | Sell |
| MA 10 | $27.96 | Buy | $27.81 | Buy |
| MA 20 | $26.90 | Buy | $27.08 | Buy |
| MA 50 | $25.07 | Buy | $25.43 | Buy |
| MA 100 | $23.03 | Buy | $24.29 | Buy |
| MA 200 | $23.66 | Buy | $24.39 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.68 | Neutral |
| Stoch RSI (14) | 42.65 | Neutral |
| CCI (20) | 73.04 | Neutral |
| Williams %R (14) | -26.68 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 9.43 | Buy |
| Bollinger %B (20,2) | 0.75 | Neutral |
| Stochastic %K (14) | 73.32 | Neutral |
| TRIX (15) | 0.52 | Buy |
| Awesome (5,34) | 2.25 | Buy |
| Ultimate (7,14,28) | 66.08 | Neutral |
| Momentum (10) | 2.38 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 28.24 | Sell |
| ADX (14) | 30.54 | Buy |
| ATR (14) | 0.38 | Info |
The near-term picture is bullish, with RSI14 at 70 and a sentiment labeled BULLISH. The stock is positioned above both the SMA50 ($24.23) and SMA200 ($23.68), suggesting a constructive trend. Support is indicated at $23.67 and resistance at $28.28, with recent activity forming a 30-day range between $25.34 and $31.56.
These technicals imply that near-term momentum is strong, while price action remains bounded by the defined support and resistance levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.88 | $28.08 | $34.91 | 0% | Neutral | |
| $27.25 | $33.27 | $42.47 | +19% | Neutral | |
| $29.18 | $36.29 | $47.58 | +29% | Bullish | |
| $32.92 | $41.57 | $55.66 | +48% | Bullish | |
| $41.06 | $52.56 | $71.64 | +87% | Bullish | |
| $46.08 | $59.71 | $82.67 | +113% | Bullish | |
| $51.20 | $67.10 | $94.23 | +139% | Bullish | |
| $55.51 | $73.50 | $104.56 | +162% | Bullish | |
| $56.71 | $75.85 | $109.19 | +170% | Bullish | |
| $61.37 | $82.85 | $120.59 | +195% | Bullish | |
| $96.48 | $135.86 | $207.23 | +384% | Bullish | |
| $195.46 | $295.18 | $482.64 | +951% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $19.88 | $28.08 | $33.48 | +0.00% |
| August 2026 | $24.06 | $28.16 | $33.66 | +0.27% |
| September 2026 | $24.25 | $28.51 | $34.35 | +1.26% |
| October 2026 | $24.79 | $29.28 | $35.51 | +2.68% |
| November 2026 | $24.52 | $29.05 | $35.43 | -0.77% |
| December 2026 | $23.96 | $28.48 | $34.91 | -1.96% |
Click any year to see its month-by-month HSTM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The HSTM price prediction for 2026 points to an average of $28.08 (low $19.88, high $34.91) — a potential gain of 0% on today's $28.08. A consolidation phase looks the most probable path here.
In 2027, HSTM is projected to trade between $27.25 and $42.47, averaging $33.27 — a potential gain of +19% from today's $28.08. That is up +18% on the projected 2026 average. Price action looks broadly range-bound.
HealthStream, Inc.'s 2028 outlook centres on $36.29, within a $29.18 to $47.58 range. That is up +9% on the projected 2027 average. That marks a +29% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, HSTM could reach as high as $55.66, with a base case around $41.57 and support toward $32.92 — roughly +48% from $28.08. Momentum favours further upside here.
Expect HSTM to range from $41.06 to $71.64 through 2030. The $52.56 average target implies a +87% move from current prices. That is up +26% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The HSTM price prediction for 2031 points to an average of $59.71 (low $46.08, high $82.67) — a potential gain of +113% on today's $28.08. Momentum favours further upside here.
In 2032, HSTM is projected to trade between $51.20 and $94.23, averaging $67.10 — a potential gain of +139% from today's $28.08. That is up +12% on the projected 2031 average. Buyers look set to stay in control over this stretch.
HealthStream, Inc.'s 2033 outlook centres on $73.50, within a $55.51 to $104.56 range. That is up +10% on the projected 2032 average. That marks a +162% change versus current levels. Momentum favours further upside here.
By 2034, HSTM could reach as high as $109.19, with a base case around $75.85 and support toward $56.71 — roughly +170% from $28.08. Buyers look set to stay in control over this stretch.
Expect HSTM to range from $61.37 to $120.59 through 2035. The $82.85 average target implies a +195% move from current prices. That is up +9% on the projected 2034 average. Momentum favours further upside here.
The HSTM price prediction for 2040 points to an average of $135.86 (low $96.48, high $207.23) — a potential gain of +384% on today's $28.08. Buyers look set to stay in control over this stretch.
In 2050, HSTM is projected to trade between $195.46 and $482.64, averaging $295.18 — a potential gain of +951% from today's $28.08. That is up +117% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in HSTM today (≈ 35.612536 HSTM) could be worth
$10,512.14
+$9,512.14 (+951%) by 2050 · US Dollar
Based on the average projected HSTM price of $295.18 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HSTMwould be worth at today's price.
$1,000 invested in HSTM on Jul 10, 2025 (≈ 36.751196 HSTM) would be worth
$1,031.97
+$31.97 (+3.2%) today · 1.03× · US Dollar
Based on a HSTM entry price of $27.21 vs. today's $28.08.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $28.41 | $988.38 | -1.2% |
| 1 month ago | $26.32 | $1,066.87 | +6.7% |
| 3 months ago | $19.88 | $1,412.47 | +41.2% |
| 6 months ago | $22.53 | $1,246.34 | +24.6% |
| 1 year ago | $27.21 | $1,031.97 | +3.2% |
| All time (5.0y) ago | $28.18 | $996.45 | -0.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HSTM forecast.
Our base-case forecast reaches $56.00 around 2031.
Implied market cap at $56.00: $1.64B
The multi-year forecast shows a clear bullish arc, with the 2026 average price at $28.28 (min $19.88, max $35.46) and ROI of 0%; sentiment is Neutral for that year. From 2027 onward, the averages rise and the ROI increases, with 2027 at $34.38 (ROI 21.6%, sentiment BULLISH) and 2028 at $37.49 (ROI 32.6%, sentiment BULLISH). By 2029, the average is $43.72 (ROI 54.6%).
In 2030 the average moves to $56.12 (ROI 98.4%, sentiment BULLISH), and 2031–2035 show continued upside with 2031 at $63.04 (ROI 122.9%), 2032 at $71.98 (ROI 154.5%), 2033 at $79.53 (ROI 181.2%), 2034 at $80.77 (ROI 185.6%), and 2035 at $90.63 (ROI 220.5%). The long horizon points to substantial appreciation, with 2040 at $148.75 (ROI 426%) and 2050 at $331.17 (ROI 1071.1%), both bullish. These are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $56.12, min $43.82, max $76.53, ROI 98.4%, sentiment BULLISH.
The forecast shows bullish sentiment in multiple years with rising averages: 2027 avg $34.38 (ROI 21.6%), 2028 avg $37.49 (ROI 32.6%), 2029 avg $43.72 (ROI 54.6%), and continuing higher through 2050 (avg $331.17, ROI 1071.1%). These are estimates, not guarantees.
Yes. The max forecasts include 2032 at $101.13 and 2033 at $113.17, with higher maxima in later years (2035 $131.95, 2040 $226.95, 2050 $541.58), indicating the potential to exceed $100 per the projected path.
Current price is $28.28. Market cap is $826.21M.
The 30-day range is $25.34 to $31.56.
HealthStream, Inc. Community Discussion
0Share your HealthStream, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.